Research and Development Department, Nacalai Tesque, Inc., Ishibashi Kaide-cho, Muko-shi, Kyoto 617-0004, Japan.
Anal Methods. 2024 Mar 28;16(13):1948-1956. doi: 10.1039/d4ay00114a.
Nucleic acids, which have been employed in medicines for various diseases, are attracting attention as a new pharmaceutical model. Depending on the target substances, nucleic acid medicines with various nucleic acid chain lengths (several tens of nucleotides [nt] to several thousands of nt) exist. The purification of synthesized nucleic acids is crucial as various impurities remain in the crude product after synthesis. Presently, reversed-phase high-performance liquid chromatography (RP-HPLC) represents an effective purification method for nucleic acids. However, the information regarding the HPLC conditions for separating and purifying nucleic acids of various chain lengths is insufficient. Thus, this technical note describes the separation and purification of short-, medium-, and long-stranded nucleic acids (several tens of nt to thousands of nt) by RP-HPLC with various mobile phases and octadecyl-based columns with various pore sizes, such as normal (9-12 nm), wide (30 nm), and super wide (>30 nm) pores.
核酸作为治疗各种疾病的药物正在引起关注,成为一种新的药物模型。根据靶物质的不同,存在具有各种核酸链长(几十到几千个核苷酸 [nt])的核酸药物。由于合成后粗产物中仍存在各种杂质,因此合成核酸的纯化至关重要。目前,反相高效液相色谱 (RP-HPLC) 是一种有效的核酸纯化方法。然而,对于分离和纯化各种链长的核酸的 HPLC 条件的信息还不够充分。因此,本技术说明介绍了通过 RP-HPLC 用各种流动相和各种孔径的十八烷基柱(如常规(9-12nm)、宽(30nm)和超宽(>30nm)孔)分离和纯化短链、中链和长链核酸(几十到几千个核苷酸)。